AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
REMDESIVIR
5 registrations across 3 African markets— 5 active
Markets with REMDESIVIR
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DESREM | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Oct 2028 |
| VEKLURY POWDER FOR SOLUTION FOR INFUSION 100 mg | 🇿🇦South Africa | Gilead Sciences South Africa (Pty) Ltd | active | Jan 1900 |
| REMDESIVIR PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | M/S HETERO LABS LIMITED | active | — |
| Remdesivir Powder for concentrate for solution for infusion 100 mg Powder for concentrate for solution for infusion | 🌍WW | Gilead Sciences Ireland UC | active | — |
| REMDESIVIR PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | M/S HETERO LABS LIMITED | active | — |
REMDESIVIR in Africa — Regulatory Overview
REMDESIVIR is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, South Africa, WW. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 5 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.